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Abstract
Background: Array comparative genomic hybridization (aCGH) to detect copy number variants (CNVs) in mammalian
genomes has led to a growing awareness of the potential importance of this category of sequence variation as a cause of
phenotypic variation. Yet there are large discrepancies between studies, so that the extent of the genome affected by CNVs
is unknown. We combined molecular and aCGH analyses of CNVs in inbred mouse strains to investigate this question.
Principal Findings: Using a 2.1 million probe array we identified 1,477 deletions and 499 gains in 7 inbred mouse strains.
Molecular characterization indicated that approximately one third of the CNVs detected by the array were false positives
and we estimate the false negative rate to be more than 50%. We show that low concordance between studies is largely
due to the molecular nature of CNVs, many of which consist of a series of smaller deletions and gains interspersed by
regions where the DNA copy number is normal.
Conclusions: Our results indicate that CNVs detected by arrays may be the coincidental co-localization of smaller CNVs,
whose presence is more likely to perturb an aCGH hybridization profile than the effect of an isolated, small, copy number
alteration. Our findings help explain the hitherto unexplored discrepancies between array-based studies of copy number
variation in the mouse genome.
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Introduction
Array comparative genomic hybridization (aCGH) using long
oligonucleotides (.50 bp) has emerged as a preferred technology
for genome-wide detection of copy number variation, structural
variation in DNA greater than 1 kilobase in size. ACGH
experiments have already shown that more than 3% of the
human genome is affected by copy number variants (CNVs) [1,2],
that there is a relationship between expression variation and copy
number variation [3,4,5,6], and that CNVs contribute to disease
susceptibility [1,7,8,9].
However the inadequacies of aCGH are also widely acknowl-
edged [10]. First, estimates of the amount of copy number
variation differ considerably: for example the fraction of the mouse
genome estimated to be copy number variant ranges from 3% [6]
to 10.7% [5]. Second, concordance between CNVs from differing
aCGH experiments is low: in human studies discrepancies occur
between analyses that assessed identical samples [2,11,12,13]; in
mouse studies there is low overlap between CNVs reported for the
same inbred strains (37% between [14] and [5]).
A number of explanations for the inconsistent results between
aCGH experiments have been considered [10]. These include the
use of different arrays and CNV detection algorithms, with varying
sensitivity, specificity and probe density [5,10], as well as technical
problems with aCGH arising from, for example, the interference
of SNPs with hybridization [15]. However the relative contribu-
tion of each factor to the low concordance between studies is not
known.
We set out to quantify the factors that affect the reproducibility
of aCGH studies. To do this we compared four published mouse
long-oligonucleotide aCGH experiments with our own analysis of
CNVs in new aCGH data from seven inbred strains of mice (A/J,
AKR/J, BALB/cJ, C3H/HeJ, CBA/J, DBA/2J and LP/J) using a
2.1 million probe NimbleGen array. The use of inbred mice, in
conjunction with one common strain used as the reference in all of
the studies (C57BL/6J), enabled us to focus on the issues associated
with the platform and detection algorithms alone, without
considering the additional population variability presented in
human copy number variation studies. We note here that
inaccuracies in the mouse reference assembly will distort detection
of CNVs [16], but since this factor will be consistent across
genome-wide studies we do not consider its impact further. We
followed up our aCGH study with an extensive validation strategy
for CNVs that combined PCR, real-time PCR, sequencing,
fluorescence in situ hybridization to interphase nuclei (FISH) and
multiplex ligation-dependent probe amplification (MLPA) [17], in
addition to a very high-density array. Our work reveals a complex
architecture in mouse CNVs that will make it even harder to
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validate and compare aCGH experiments than previously
thought.
Results
Detecting CNVs in Seven Inbred Strains
Using a 2.1 million probe NimbleGen array (2.1M array) we
performed CGH experiments for seven inbred mouse strains (A/J,
AKR/J, BALB/cJ, C3H/HeJ, CBA/J, DBA/2J and LP/J; collec-
tively termed the test strains), all co-hybridized with genomic DNA
from C57BL/6J (the reference strain). We began our analyses by
processing the aCGH data to account for SNP effects on probe
hybridization, as previous work suggests that this will improve the
specificity and sensitivity of automated CNV detection [15].
We quantified the impact of SNPs on hybridization (measured
as the log2 transformed ratio of the test versus reference
hybridization signals). The effect is surprisingly large: by matching
probe location to the set of 8.27 million SNPs published by
Perlegen Sciences (CA,USA) [18] (Tables S1 and S2), we found
that each SNP decreases the log2 ratio by 0.5 on average (so
adding two SNPs halves the hybridization signal) (Table 1 and
Figure 1A); Figure 1B depicts the distributions of log2 ratios after
they have been standardized for probe SNP content. In addition,
the effect of a SNP depends on its position within a probe (Figure 2
and Table S3). This observation is consistent with our analysis
of the effects of SNPs on expression quantitative trait loci (eQTLs)
[19].
We called CNVs using SW-ARRAY [20]. We found 1,477
deletions across the seven test strains, and 499 gains. Table S4
gives the CNV coordinates. Deletions have a median length of
44.2 Kb and cover an average of 33.3 Mb per strain (1.3%),
whereas gains have a median length of 53.2 Kb and cover only
13.8 Mb per strain (0.54%) (Table 2). The minimum detectable
CNV length was ,1 Kb, corresponding to the probe spacing on
our array (median 1,136 bp), and the use of SW-ARRAY and
permutation testing to assess the significance of any CNV call; in
practice the majority of CNVs were longer than this (10th
percentile 7.9 Kb). For some of our analyses it was useful to merge
overlapping CNVs detected in different strains into CNV regions
[2,5,6]; merging yielded 600 deletion- and 183 gain-CNV regions
(Table S5). Of the 600 deletion-CNV regions, 330 are present in
more than one strain (55%). 108 out of the 183 gain-CNV regions
are present in more than one strain (59%). Combining these two
sets gives 755 non-overlapping CNV regions. Approximately 113
Mb (4.4%) of the C57BL/6J genome is identified as a CNV region.
Fifteen regions contain both deletions and gains. Our estimate of
CNV content is comparable to that predicted by a similar study
(3% [6]), but much less than that observed in Henrichsen et al. [5]
(10.7%).
Biological Characteristics of CNV Regions
We analyzed the genomic content and functional impact of
CNV regions. In line with a previous study [6], we classified CNV
regions by length (small (,10 Kb), medium (10–100 Kb) and large
(.100 Kb)), and then characterized their repetitive sequence
content.
Since one proposed mechanism for CNV formation is non-
allelic homologous recombination (NAHR) [21], sequence features
that are recombination substrates may act as CNV nurseries. We
assessed CNV region content for such features and tested for
significant enrichment by permutation; results are given in Table
S6. We found that segmental duplications (SDs) and long tandem
repeats (LTRs) are enriched within and around medium and large
CNV regions, and that long interspersed repetitive elements
(LINEs) are enriched within them, and also in the flanking
sequence of large CNV regions. Conversely, short interspersed
repetitive elements (SINEs) are depleted in CNV regions .10 Kb.
These results are largely in agreement with previous analyses [6],
as were our results for short CNV regions: LINEs are depleted in
them; SDs are depleted within and around them; whilst LTRs and
SINEs are neither enriched nor depleted.
A Gene Ontology (GO) enrichment analysis produced very
similar results to those obtained for human-CNV genes [22] and
for mouse-CNV genes [14] (Table S7). Specifically, genes involved
Table 1. Probe SNP content versus probe hybridization.
SNP content Regression on SNP content
Strain 0 1 2 .2 P-value slope R2
A/J 0.02 20.50 20.88 21.14 0 20.50 0.040
AKR/J 0.02 20.50 20.87 21.18 0 20.50 0.049
BALB/cJ 0.04 20.54 21.03 21.25 0 20.57 0.054
C3H/HeJ 0.03 20.40 20.86 21.23 0 20.44 0.043
CBA/J 0.05 20.45 20.84 21.15 0 20.46 0.036
DBA/2J 0.03 20.40 20.86 21.20 0 20.44 0.038
LP/J 0.02 20.45 20.83 20.94 0 20.47 0.053
A/J (d.s.) 0.03 20.50 21.00 21.24 0 20.54 0.061
AKR/J (d.s.) 0.06 20.50 21.03 21.45 0 20.57 0.057
BALB/cJ (d.s.) 0.04 20.52 21.00 21.30 0 20.56 0.051
C3H/HeJ (d.s.) 0.06 20.55 21.13 21.48 0 20.61 0.059
CBA/J (d.s.) 0.04 20.53 21.08 21.58 0 20.57 0.051
DBA/2J (d.s.) 0.03 20.61 21.03 21.31 0 20.61 0.060
LP/J (d.s.) 0.03 20.45 20.80 21.04 0 20.48 0.046
For each strain, the median log2 ratios for probes with zero, one, two and more than two SNPs are shown. A linear regression analysis was conducted to fit a linear
model to the data for each strain. The P-value, slope and the square of the correlation coefficient (R) are shown for all the experiments (d.s. = dye swap).
doi:10.1371/journal.pone.0012839.t001
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with immunity (for example: ‘‘antigen binding’’, ‘‘defense
response’’, ‘‘immune response’’ and ‘‘antigen presentation by
MHC class I’’) are all enriched in CNV regions, as are those
related to environmental sensory (‘‘odorant binding’’ and
‘‘pheromone binding’’). In contrast, genes related to basic cellular
processes (‘‘nucleus’’, ‘‘DNA binding’’ and ‘‘protein binding’’) are
all significantly under-represented in CNV-region genes.
We also analyzed the effect of copy number variation on gene
expression using genome-wide expression data in three tissues
(brain (hippocampus), liver and lung), from the inbred strains [19].
In agreement with previous studies [5], we found that the
expression variance of transcripts mapping within CNV regions is
greater than that of transcripts mapping elsewhere on the genome
(Table S8), and that CNVs affect transcript expression levels by
altering transcript dosage, although this was not always the case
(Table S9 and Figure S1).
Comparison with Previously Reported CNVs
Tables 2 and 3 report respectively comparisons of CNV
numbers and replication rates between this study and four other
genome-wide experiments [5,6,14,23]; Table S10 collates the data
for all the CNVs from these five studies. Using our CNVs we
attempted to quantify factors that give rise to variation between
studies.
First, to establish an upper bound on the reproducibility of
aCGH, we compared the CNV calls in our initial experiments to
those obtained in technical replicates (for each strain we repeated
each experiment in dye swap using DNA from the same animal).
In the remainder of this section we refer to the overlap between
two sets of CNVs as the number of CNVs in their intersection,
divided by the number of CNVs in their union; hence there was
a mean overlap of 0.44 for deletions (variance = 0.0051, min
= 0.37, max = 0.57), and 0.50 for gains (variance = 0.0077, min
= 0.37, max =0.62) between technical replicates.
We examined the effects on reproducibility of changing the
biological sample, CNV detection algorithm, and microarray
platform. We assessed each factor, while the others were fixed.
Assessing differences in biological samples is simplified in mouse
analyses due to the availability of inbred strains. We compared
CNVs called in animals of the same strain using the same platform
and algorithm (data published by Henrichsen et al. [5]), and
found a mean overlap of 0.43 for deletions (variance = 0.013, min
= 0.15, max = 0.59) and 0.25 for gains (variance = 0.020, min
= 0.056, max = 0.60). Thus technical replicates (i.e. dye-swap
experiments) produce more consistent results than biological
replicates.
To establish the effect of changing CNV detection algorithms,
we compared the CNV calls published by Cahan et al. [6] to the
putative CNVs that we detected in their raw data using SW-
ARRAY; this gave a mean overlap of 0.49 for all CNVs (variance
= 0.0019, min = 0.44, max = 0.54). We were unable to calculate
separate results for deletions and gains because not all of the CNVs
published by Cahan et al. [6] were categorized as such.
Finally, we considered the effect of changing platforms by
comparing our CNVs to those obtained in an earlier experiment in
which we used a lower density NimbleGen array with ,385,000
Figure 1. Distribution of log2 ratios from probes with and without SNPs, before and after standardization. A: Box and whisker plots of
log2 ratios from probes with zero, one, two and more than two SNPs in their sequence in the A/J versus C57BL/6J experiment (normal dye); the boxes
represent the inter-quartile ranges of the distributions, the whiskers are 1.5 times the inter-quartile range, and red crosses are outliers. The median
log2 ratios from probes with zero, one, two and three or more SNPs are 0.02, 20.50, 20.88 and 21.14, respectively. B: Box and whisker plots of the
standardized log2 ratios from probes with zero, one, two and more than two SNPs.
doi:10.1371/journal.pone.0012839.g001
Figure 2. SNP effect depends on position within probe. Log2
ratios of probes containing one SNP were classified by the position of
the SNP within the probe (probes were divided into 11 segments of
equal length, and symmetrical segments combined to form one
category; so log2 ratios from probes with SNPs in either of the
outermost segments were grouped together, and so on). Shown here
are the median log2 ratios from each category, in each strain.
doi:10.1371/journal.pone.0012839.g002
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Table 2. Numbers, total sizes and fraction of genome coverage, relative to C57BL/6J, of putative deletions and gains found in five
long-oligonucleotide aCGH studies of CNV in the mouse genome.
Deletions Gains Abnormal CNVs
Study Strain No. Mb % No. Mb % No. Mb %
Agam et al. A/J 183 26.42 1.03 78 12.38 0.48
" AKR/J 193 35.00 1.36 70 11.64 0.45
" BALB/cJ 253 38.15 1.48 98 17.20 0.67
" C3H/HeJ 340 43.35 1.69 83 16.90 0.66
" CBA/J 181 29.65 1.15 70 8.41 0.33
" DBA/2J 206 39.99 1.56 44 12.94 0.50
" LP/J 121 20.35 0.79 56 17.10 0.67
" Mean 211 33.27 1.29 71 13.79 0.54
Graubert et al. A/J 1 0.42 0.02 2 0.53 0.02
" AKR/J 10 1.59 0.06 4 0.74 0.03
" BALB/cJ - - - - - -
" C3H/HeJ 8 1.52 0.06 2 0.53 0.02
" CBA/J - - - - - -
" DBA/2J 10 1.08 0.04 2 0.53 0.02
" LP/J - - - - - -
" Mean 7 1.15 0.04 2 0.59 0.02
Cutler et al. A/J 33 4.20 0.16 13 0.94 0.04
" AKR/J 22 3.39 0.13 18 1.41 0.05
" BALB/cJ 36 5.79 0.23 28 6.39 0.25
" C3H/HeJ 25 3.68 0.14 11 0.77 0.03
" CBA/J 29 4.15 0.16 18 2.04 0.08
" DBA/2J 24 3.92 0.15 7 0.60 0.02
" LP/J 26 4.56 0.18 9 1.45 0.06
" Mean 27 4.24 0.17 14 1.94 0.08
Henrichsen et al. A/J 179 14.30 0.56 28 3.21 0.12
" AKR/J 136 10.37 0.40 25 2.47 0.10
" BALB/cJ - - - - - -
" C3H/HeJ - - - - - -
" CBA/J - - - - - -
" DBA/2J 161 13.57 0.53 31 3.14 0.12
" LP/J 158 12.62 0.49 44 5.18 0.20
" Mean 158 12.72 0.49 32 3.50 0.14
Cahan et al. A/J 138 2.51 0.10 32 0.83 0.03 140 15.82 0.62
" AKR/J 159 2.32 0.09 20 0.81 0.03 143 18.42 0.72
" BALB/cJ - - - - - - - - -
" C3H/HeJ 135 2.02 0.08 31 0.79 0.03 139 15.93 0.62
" CBA/J - - - - - - - - -
" DBA/2J 156 2.49 0.10 24 0.80 0.03 135 17.95 0.70
" LP/J - - - - - - - - -
" Mean 147 2.33 0.09 26 0.81 0.03 139 17.03 0.66
Only CNVs found in strains studied here have been included. Experimental designs differed: Graubert et al. [23] used 20 inbred test strains, with one animal per strain,
conducted their experiments on a NimbleGen 385K array, and used CBS [35] to detect CNVs; Cutler et al. [14] tested 41 inbred strains, used two animals per strain (in dye
swap replicates), conducted their experiments on an Agilent 244K array, and used the detection algorithm GLAD [38]; Henrichsen et al. [5] analyzed 12 inbred strains (as
well as 21 wild mice), tested three individuals per strain for CNVs, also employed a NimbleGen 385K array, and used an in-house HMM to detect CNVs; finally, Cahan
et al. [6] tested 19 inbred strains, pooling the DNA of two to six animals per strain, conducted their experiments on a NimbleGen 2.1M array, and used wuHMM [15] for
CNV detection. Note that Cahan et al. [6] classified CNVs as ‘gain’, ‘loss’ and ‘abnormal’, and that the copy number status of abnormal CNVs was not published.
doi:10.1371/journal.pone.0012839.t002
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probes (385K array), but with DNA from the same animals and
employing SW-ARRAY for CNV detection (Methods S1, Table
S11). In that experiment we found 121 deletions and 48 gains,
with median lengths 178.3 Kb and 126.7 Kb respectively. CNVs
from the lower density array had a high concordance with the
2.1M array CNVs (85.1% of deletions and 81.6% of gains
were replicated), but since the high-density array detected so
many more CNVs the overlap between the experiments is low
(0.07 for deletions (variance = 0.0006) and 0.08 for gains
(variance = 0.0004)). Almost all the non-replicated CNVs
(98.7% of singleton deletions and 98.0% of singleton gains) were
found by the 2.1M array.
Molecular Validation
We next assessed the false positive rates in aCGH by
independent molecular validation of a subset of CNV regions
(44 deletions and 17 gains). To do so, we used a combination of
PCR, sequencing, real-time PCR, FISH and MLPA (Table S12).
We found that 14 of 44 deletions (32%), and 6 of 17 gains (35%),
were false positives.
Molecular characterization revealed an unexpected feature of
the validated CNV regions. In 21 of 61 cases (34%; 16 deletions
and 5 gains), PCR results from sequential sites within the CNV
region indicated that the whole segment was either deleted or
gained. We refer to CNV regions with this pattern of results as
simple. However 19 of 61 CNV regions (31%; 13 deletions and 6
gains) consist of smaller CNVs interspersed with non-CNV
segments, or contain mixed segments of gains and deletions; we
classify such CNV regions as complex (Figure 3).
The distinction between simple and complex CNV regions
correlates with reproducibility between studies; simple CNVs were
easier to detect on aCGH than complex CNVs. The majority of
our simple CNVs were found in another study [6], but this was not
the case for complex CNVs or false positives (x2 test of 263
contingency table yielded P =0.005 (x2 = 10.5, d.f. = 2) for
deletions, and P=0.001 (x2 = 14.8) for gains) (Figure 4).
We investigated whether the rates of false positive detection
could be improved by applying a stringent threshold to the log2
ratios, as reported in Cahan et al. [6]. To do this, we focused on
the set of deletion-CNV regions in our molecular validation
pipeline and examined each deletion’s mean standardized log2
ratios. These deletions were grouped by strain, and then
categorized as ‘simple’, ‘complex’ and ‘false positive’, depending
on the molecular validation result of the corresponding CNV
region (Figure 5A and B, and Figure S2 A to E). We found that
false positive deletions can have large negative mean standardized
log2 ratios, suggesting that this is not a good indicator of the
accuracy of a CNV call.
In five of the seven test strains (A/J, AKR/J, CBA/J, DBA/2J
and LP/J) it was possible to find a threshold for the standardized
log2 ratios that yielded a 0% false positive rate, but this entailed
rejecting more than 50% of the verified deletions (that is, those
deletions determined to be either simple or complex by molecular
validation: Figure 5C and Figure S2 F to I); in the remaining two
test strains (BALB/cJ and C3H/HeJ) the false positive deletions
have the largest negative mean standardized log2 ratios, so the
threshold required for a 0% false positive rate also rejects all
verified deletions (Figure 5D and Figure S2 J).
Finally, we used a very high-density array (mean probe spacing
of 214 bp) to interrogate 241 deletion-CNV and 105 gain-CNV
regions identified by the 2.1M array across the 7 test strains. We
excluded 15 regions where there is an overlap between deletions
and gains on different strains. The targeted array classified
approximately 30% of these CNVs as complex (Figure 6). We then
used the data to estimate the false negative rate in our experiment.
For each strain we determined the structural variant present (or
absent) in each of the targeted CNV regions, irrespective of
whether the strain in question carried a corresponding CNV
Table 3. Fraction of CNVs, from each study, replicated by CNVs in other studies.
Deletions
Graubert Cutler Henrichsen Cahan Agam
% Graubert et al. 60.3 88.7 67.7 79.3
% Cutler et al. 17.0 44.3 56.8 61.5
% Henrichsen et al. 5.6 15.0 32.3 33.9
% Cahan et al. 1.3 3.5 8.6 29.8
% Agam et al. 2.5 6.8 20.1 38.2
Gains
Graubert Cutler Henrichsen Cahan Agam
% Graubert et al. 59.4 82.4 100 100
% Cutler et al. 7.9 38.6 66.4 41.3
% Henrichsen et al. 10.2 22.7 39.9 27.3
% Cahan et al. 2.1 15.1 6.9 25.2
% Agam et al. 3.6 8.4 12.9 23.3
Abnormal CNVs
Graubert Cutler Henrichsen Cahan Agam
% Cahan et al. 4.1 9.6 22.9 46.3
Each row gives the percentage of CNVs from one study replicated by each of the remaining studies (columns); for example, 17.0% of deletions identified by Cutler et al.
[14] were also identified by Graubert et al. [23], whereas 60.3% of deletions identified by Graubert et al. [23] were also found by Cutler et al. [14]. In each pairwise com-
parison, only the CNVs from strains common to both studies were included. A CNV was counted as replicated if it had at least partial overlap with a CNV on the same
strain in another study. Note that, because Cahan et al. [6] has a classification for abnormal CNVs separate from deletions and gains, we used the sum total including
abnormal CNVs to calculate the fraction of deletions and gains in any one study which are replicated by this study [6].
doi:10.1371/journal.pone.0012839.t003
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Figure 3. Example of a simple, false positive and complex CNV region. Here we show an example for each class of deletion-CNV region: A)
simple, B) false positive and C) complex. Graphics on the left hand side show the distribution of CGH signal intensities in eight inbred strains of mice:
CNVs in the Mouse Genome
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according to the 2.1M array experiment. Since we expected the
very high density array to be more accurate than the 2.1M array,
we assumed that the CNVs detected there were a more accurate
assessment of whether a CNV was present; hence we estimated the
false negative rate by counting the number of regions in which the
targeted array detected structural variation, but where the 2.1M
array did not. On average, each strain had 190 targeted regions
containing structural variation, 54.5% of which had not given rise
to a CNV signal in the 2.1M array experiment.
We attempted to confirm this false negative rate using our
molecular validation data. Each time we used PCR to validate a
CNV call from the 2.1M array we checked whether that CNV was
present or absent in all seven strains. The array might for example
have identified a CNV in strain AKR/J but not in A/J, and we can
therefore check not only whether the CNV is indeed present in
AKR/J (false positive) but also whether it is missing in A/J (false
negative). Using this approach, we found a mean false negative
rate of 14.5% per strain for deletions and 19% per strain for gains.
Discussion
Using a large data set of CNVs discovered in strains of inbred
mice, we have quantified factors that contribute to discrepancies
between aCGH studies. First, by comparing technical replicates
from one experiment we have shown that the baseline reproduc-
ibility of aCGH experiments is low, consistent with a previous
comparison of different array platforms [24]. Second, the choice of
CNV detection algorithm makes a smaller but still significant
contribution to discordance between studies than the combined
effects of low reproducibility of aCGH and different biological
samples. Third, platforms with very similar protocols for probe
design and hybridization can produce highly concordant results
(more than 80% of CNVs detected in the 385K array data were
recapitulated in the 2.1M data), but probe density is a limiting
factor for the detection of small CNVs, making it very hard to
draw conclusions from comparisons between CNV sets detected
using platforms of widely differing resolutions. Finally, molecular
validation of CNVs, using a variety of independent methods,
indicated that approximately one third of the CNVs detected by
the 2.1M array were false positives.
Of the four mouse aCGH experiments reviewed here only one
[6] used independent experimental techniques (PCR and real-time
PCR) to validate more than ten of their putative CNVs (61 of
3,359). Across all the experiments we reviewed, the average
number of PCR primers used to validate each CNV was less than
2 (Table S13). We validated 61 CNV regions, with a mean of 7
PCR primers per region. We note that other studies have used
very high-density arrays to validate CNV regions [5], but consider
that this technique is less informative than PCR-based assays
because it is prone to the same confounds as the original
experiments, discussed above.
With this caveat on the use of high-density arrays for
determining the accuracy of CNV calls from array based
experiments, we tackled the more difficult problem of identifying
A/J, AKR/J, BALB/cJ, C3H/HeJ, C57BL/6J, CBA/J, DBA/2J and LP/J. The X-axis is the position in Mb and the Y-axis is the log2 ratio (averaged in windows of
5 probes for A and B and 40 for C). Images on the right hand side constitute a representative set of independent validation experiments. A: 39 Kb
simple deletion identified in DBA/2J on Chr 2: 141.669 Mb–141.708 Mb. Tiling PCR primers are displayed at the top of the graph. In total, we designed
9 tiling primers (t1 to t11), each amplifying regions of ,1.2 Kb across the region and its 59 flanking region. We highlight a representative set in pink
(primers t6, t8, t9 and t11) for which PCR results are shown on the right of the graphic. See Table S12 for details of all primers and PCR results. This
deletion lies within intron 8 of the gene Macrod2 [36]. B: 220 Kb false positive deletion identified in all the test strains, on Chr14: 69.87 Mb–70.09 Mb,
in our 385K aCGH study. We designed 36 tiling primers spanning the region (represented at the top of the graphic). PCR results showed amplification
in all 8 strains (Table S12) suggesting a false positive deletion. We also carried out FISH experiments. We used two BACs, RP24-334N5 (Chr 14: 69.9
Mb–70.07 Mb) for the test region on chromosome 14 and RP23-293B18 (Chr 17: 30.83 Mb–31.0 Mb) as a positive gain control on mouse chromosome
17. FISH data show that the region is not deleted. C: 2.44 Mb fragmented deletion identified in all the test strains on Chr 4: 111.58 Mb–114.02 Mb.
PCR results are shown for 8 representative tiling primers out of a total of 32 (highlighted in pink). There is no amplification in the test strains from t2
to t11, t16 to t27 and t29, thus validating the deletion. However, primers t1, t12 to t15 and t28 have amplified in all strains. Genes are represented at
the top using grey arrows. The first deletion affects Skint4, Skint3 and Skint9 [37], and the second deletion affects Skint6 and Skint5; the latter finding
has not been reported previously.
doi:10.1371/journal.pone.0012839.g003
Figure 4. Concordance between studies for simple, complex and false positive CNVs. A: Deletion-CNV regions detected in our
experiments were determined, by molecular validation, to be either simple (blue), complex (green) or false positive (red); their constituent CNVs were
classified accordingly. Examining only the CNVs detected in the four strains which were common to both our study and the Cahan et al. study [6] (A/J,
AKR/J, C3H/HeJ, DBA/2J), we established, for each category, the frequency of our deletions replicated and not replicated; a CNV was counted as
replicated if it had at least partial overlap with a CNV on the same strain in that study. B: Similarly for gains.
doi:10.1371/journal.pone.0012839.g004
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Figure 5. Distribution of mean standardized log2 ratios in simple, complex and false positive deletions. A: Distribution of the mean
standardized log2 ratios in simple (blue), complex (green) and false positive (red) A/J deletions that were included in the molecular validation
experiments described in the main text. B: Similarly for BALB/cJ. C: We examined all thresholds for accepting a deletion between 21 and 214. For
each threshold we plot the false positive rate (FPR), calculated as the percentage of all accepted deletions that are false positives, against the
percentage of all verified deletions that are rejected (where verified deletions are defined as those which were categorized as either simple or
complex in the molecular validation experiments). Results are shown for A/J. D: Results are shown for BALB/cJ. (See Figure S2 for the remaining test
strains).
doi:10.1371/journal.pone.0012839.g005
Figure 6. Complex CNV architecture elucidated by targeted high-density aCGH. Three CNVs in C3H/HeJ, inspected using the targeted
array; the red line is the median log2 ratio observed in control regions, blue dots are the SNP standardized log2 ratios for each probe in the region,
and the blue line is the smoothed signal (using a window size of 10% of the number of probes). A: Putative deletion on Chr 1: 95.74 Mb–95.89 Mb is
composed of two smaller deletions, separated by a region of normal copy number. B: Putative deletion on Chr 16: 49.34 Mb–49.37 Mb harbors a
small gain. C: Putative gain on Chr 18: 31.78 Mb–31.80 Mb is composed of two smaller gains separated by a region of normal copy number.
doi:10.1371/journal.pone.0012839.g006
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false negatives using a targeted array to examine regions where no
CNV had been called by the 2.1 M array. The array comparison
identified a false negative rate of 54.5%, a figure that we attempted
to corroborate using data from our molecular validation
experiments. The latter indicated a false negative rate of 14.5%
for deletions and 19% for gains, substantially lower than those
obtained from the between-array comparison. However we believe
the array-comparisons figure is a better estimate, because the
molecular validation strategy only interrogates a small fraction of
the region predicted to have a CNV. Since many CNVs are
complex, with regions of deletion or gains interspersed with
regions of non-CNV DNA, a proportion of the PCR validations
will, by chance, have missed the CNV. This will have resulted in
an underestimate of the false negative rate. Thus the molecular
validation result can be regarded as a lower bound on the false
negative rate. Additional support for the 54.5% figure comes from
the biological features of our CNVs, which are also found by
others. The commonality suggests that many of the CNV calls
found in different studies are correct, true positives, and that the
low concordance between publications must therefore be attrib-
uted to large numbers of false negatives.
One source of variation between studies is likely to be the
presence of CNVs segregating within inbred strains. For instance a
survey of only five chromosomes at relatively low resolution
identified CNVs segregating in C57BL/6J mice [25]. Since most
studies use only a few animals from each strain and do not look at
pedigrees, the full impact of this source of variation has yet to be
quantified.
Our results help explain why aCGH experiments differ, and
also how those differences can be avoided. First, we show that the
effects of known SNPs in probes can be ameliorated by a novel but
simple pre-processing step that accounts for SNP content, and
allows us to retain affected probes in the analysis. We expect the
results will be improved once a complete SNP catalogue is
available. Second, technical and biological variation is a major
cause of discrepant findings. Assuming the sources of this variation
are random, simply repeating the experiment enough times should
reduce the error. Consequently CNVs found by multiple studies
are more likely to be true positives. However our work suggests
that there is another source of variation, whose importance has not
hitherto been fully appreciated, that complicates this simple
solution.
Low concordance between studies is in part due to the
molecular nature of CNVs. We have found that many CNVs
consist of a series of smaller deletions and gains interspersed by
regions where the DNA copy number is normal [26,27].
Discrepancies between studies are more likely to occur when
detecting these complex CNVs, compared to the simpler deletions
and gains. This is because hybridization signals from multiple
probes are used to detect a CNV and so, within a complex CNV,
only a fraction of probes are likely to detect changes in genome
content. Arrays interrogating the same CNV region in the same
individual would be expected to yield inconsistent results if the
probes are in different locations; in one case they identify copy
number changes while in the other they may not. ‘False positives’
may therefore be true positives that array probes were incorrectly
placed to detect.
Our dichotomous classification of CNVs into simple and
complex, though useful in interpreting aCGH data, may be
artefactual. Simple CNVs do not appear to possess a unique
biological identifier. We could find no sequence feature, strain
distribution patterns of sequence variants, or hybridization
signature that would enable their unambiguous identification.
Furthermore, data from dense arrays reveal a spectrum of CNVs
[1], from small insertion-deletions to megabase scale structural
variants. Complex CNVs may simply be the coincidental co-
localization of smaller, simpler CNVs, whose presence is more
likely to perturb the aCGH hybridization profile than an isolated,
small copy number alteration. The detection and characterization
of complete sets of CNVs will require the application of next
generation sequencing which will doubtless reveal yet more
unexpected features of the molecular nature of structural variation
across the genome.
Materials and Methods
Mouse DNA Samples
DNA of male mice from eight inbred strains (A/J, AKR/J,
BALB/cJ, C3H/HeJ, C57BL/6J, CBA/J, DBA/2J and LP/J) was
purchased from the Jackson Laboratory (JAX, http://www.jax.
org) at a concentration of 1 mg/ml. DNA was diluted 1 in 5, giving
a working concentration of 200 ng/ml. 50 ml was sent to
NimbleGen (Iceland) for aCGH work.
NimbleGen 2.1 Million Probe Array
We conducted a comparative genomic hybridization experi-
ment using a NimbleGen long-oligonucleotide array containing
,2.1 million probes. The probes are 50–75mers selected from a
C57BL/6J Build 37 tiling database. They span all chromosomes,
are evenly spaced, and have been designed to be isothermal (as far
as possible) to ensure uniform hybridization behaviour. Consid-
ering only the autosomal chromosomes, there were 1,967,439
probes with mean, median, 90th and 99th percentile spacing of
1,228, 1,135, 1,206 and 3,574 bp, respectively. The maximum
spacing between probes is 7 Mb on chromosome 7: 39–46 Mb,
where there is a gap in the C57BL/6J sequence.
Array Processing and CNV Detection
Normalization of hybridization signals was performed by
NimbleGen using standard protocols. We removed probes whose
sequences contained repeats as identified by RepeatMasker [28],
leaving 1,748,617 probes with a mean spacing of 1,381 bp, and
50th, 90th and 99th percentile spacing of 1,136, 1,832 and 6,679 bp
(Materials S1, Figure S3).
Within each strain, probes were annotated for SNP content
(using only the sequence variants between the strain and C57BL/
6J) based on the Perlegen Sciences SNP set [18]. Then log2 ratios
were grouped together according to the number of SNPs in their
corresponding probe (zero, one, two and more than two). To
measure the effect of SNPs on probe hybridization a linear
regression analysis was conducted with SNP content and log2 ratio
as the explanatory and dependent variables, respectively. Finally,
the distribution of log2 ratios in each group was standardized by
subtracting the group’s median from each log2 ratio, and then
dividing by the group’s median absolute deviation.
CNVs were called using SW-ARRAY [20] with deletion and
gain thresholds set at the 10th and 90th percentiles of the
standardized distribution of log2 ratios within each strain. Only
CNVs significant at a genome-wide 5% significance threshold
(determined by permutation) were reported. Then we applied a
post-processing step to remove CNVs with a low probe density
(Materials S1). Finally, each comparison between a test strain and
C57BL/6J comprised a normal and dye swap hybridization using
DNA samples from the same animal; we processed each
independently using the above pipeline, and then only those
CNVs that were at least partially replicated in both experiments
were reported.
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Permutation Testing for Significance of CNV Region
Genomic Content
We have observed that CNV regions cluster (Materials S1,
Figure S4). Therefore simply permuting CNVs randomly across
the genome (as has been done previously [6]) is inappropriate
because the clustering is lost. We used a novel method for CNV
region permutation that maintains clusters called rotational
permutation (Materials S1, Figure S5).
Using this method we generated 1000 permuted CNV region
sets. Then, for each biological feature of interest, we generated an
empirical null distribution of its overlap with CNV regions by
calculating and recording the percentage of CNV region bases that
overlapped it in each of the permuted sets. We then calculated the
percentage of real CNV region bases that overlapped the feature,
and compared this to the null distribution to obtain a P-value.
Gene Ontology Enrichment Analysis
We used the pipeline for GO enrichment analysis of CNVs in
Nguyen et al. [22]; the likelihood that a GO annotation is over- or
under- represented among CNVs is estimated using the hypergeo-
metric distribution, and then the false discovery rate (FDR) is
controlled (here it was kept at 5%) to select the most significant results.
Calculating Overlap between CNV Sets
Determining the overlap between two sets of CNVs was a two
step procedure:
(i) CNVs located on the same strain in both experiments, and
which had at least partially overlapping genomic coordinates,
were grouped into CNV regions; CNVs that were only
detected in one of the experiments became singleton CNV
regions.
(ii) The overlap statistic was calculated as the number of CNV
regions containing more than one CNV, divided by the total
number of CNV regions.
Analysis of Cahan et al. Array CGH Data
Array CGH data from the study published by Cahan et al. [6]
were downloaded from the NCBI GEO website (http://www.ncbi.
nlm.nih.gov) using accession code GSE10656. For each of our test
strains included in that study (A/J, AKR/J, C3H/HeJ and DBA/2J),
we extracted the normalized log2 ratios (rather than using the raw
intensity data directly). We performed our SNP standardization
before applying SW-ARRAY to detect CNVs; note that probes with
a high repeat content were not removed for this analysis. We chose
stricter thresholds for SW-ARRAY (the 5th and 95th percentiles of
genome-wide log2 ratios for deletions and gains, respectively) than
we had for own data; doing so reduced the number of CNVs
compared to those obtained with thresholds set at the 10th and 90th
percentiles, and improved their concordance with the published
CNVs [6]. We kept all CNVs significant at a genome-wide 5%
significance threshold, regardless of their probe density.
PCR, Sequencing and Multiplex Ligation Probe
Amplification (MLPA)
Primers were designed using Primer3 [29] and purchased from
MWG (Germany). Three independent PCR reactions were carried
out with Hotstar Taq obtained from Qiagen (Germany). Reactions
were performed as previously described [30]. PCR products were
purified in a 96-well Millipore purification plate resuspended in
30 ml of H2O and sequenced as previously described [30]. All
sequencing reactions were run out on an ABI3700 sequencer and
assembled by using PHRED/PHRAP [31]. Consed was then used
for editing and visualization of the assembly [32]. For quantification
of gene relative copy number, we used the comparative Ct method
[33]. The Ct values for each set of triplicates were averaged. Ct
values were normalized against a control primer. The number of
copies for each strain was calculated as 2‘(normalized Ct for test
strain – normalized Ct for reference strain). MLPA primers were
designed to hybridize to regions without sequence polymorphisms
and MLPA was performed using published protocols [34]. Internal
controls from regions with a CNV were included in the MLPA
analyses. Data were analyzed using Applied Biosystems Peak
Scanner software and MRC-Holland Coffalyser software (http://
old.mlpa.com/coffalyser).
Fluorescence In Situ Hybridization (FISH)
Bacterial artificial chromosome (BAC) clones mapping to the
relevant regions of the genome were purchased from Geneservice
(Cambridge, UK; http://geneservice.co.uk). All BACs are derived
from inbred strain C57BL/6J. BACs were prepared and
hybridized to mouse chromosomes as previously described [30].
Targeted High-Density Array
NimbleGen designed a targeted array to interrogate 348 CNV
regions (241 deletions and 107 gains) at a probe density of
approximately one every 214 bp. In addition, ten 50 Kb negative
controls (regions where there are no known CNVs in any of the test
strains) were included on the array. Only probes with no repetitive
sequence content were allowed.We standardized the data to account
for probe SNP content, as described for the 2.1M array above. Then,
for each test strain, we analyzed each CNV region as follows:
(i) We segmented the data from the region using the MATLAB
Bioinformatics Toolbox implementation of Circular Binary
Segmentation ([35], http://www.mathworks.com/access/
helpdesk/help/toolbox/bioinfo/ref/cghcbs.html), with the
default parameters.
(ii) Then we tested each segment using a method similar to that
proposed by Henrichsen et al. [5]: we used the Mann-
Whitney U test to determine whether the standardized log2
ratios from probes in the segment were significantly different
from those obtained in the control regions (P,0.05); if they
were, we declared the segment to be a CNV if the median
standardized log2 ratio in the segment was .2 x s.d.(median
standardized log2 ratios in control regions).
(iii) If we determined that at least one segment of the region was
a CNV, then we declared the whole region to be copy
number variant in the strain of interest.
Supporting Information
Figure S1 Correlation between transcript CNV status and
expression. For each strain, in each tissue, box and whisker plots
of the normalized relative expression (calculated as the ANOVA
logP, see Table S8 legend) for all differentially expressed
transcripts are shown. Transcripts are classified according to their
CNV status: deletion (black), non-CNV (grey), or gain (white). The
number of probe sets in each sample is shown under the boxplots.
Found at: doi:10.1371/journal.pone.0012839.s001 (0.49 MB
DOC)
Figure S2 Distribution of mean standardized log2 ratios in
simple, complex and false positive deletions. A-E: Distribution of
the mean standardized log2 ratios in simple (blue), complex (green)
and false positive (red) deletions in AKR/J, CBA/J, DBA/2J, LP/J
CNVs in the Mouse Genome
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and C3H/HeJ, respectively. F-J: We examined all thresholds for
accepting a deletion between -1 and -14. For each threshold we
plot the false positive rate (FPR) against the percentage of all
verified deletions that are rejected. Results are shown in the same
strain order as for plots A-E.
Found at: doi:10.1371/journal.pone.0012839.s002 (0.64 MB
DOC)
Figure S3 Relationship between probe repeat content and
hybridization. A: Box and whisker plots of the log2 ratios from
probes in the 2.1M array A/J versus C57BL/6J normal dye
experiment. Probes are grouped by repeat content. Probes either
have no repetitive sequence at all, or they are found to have a
minimum of 33% (this is due to the algorithm and default settings
used by RepeatMasker). B: Chromosome 1 log2 ratio profile, with
repetitive probes highlighted in green. Such probes constitute
11.1% of all probes.
Found at: doi:10.1371/journal.pone.0012839.s003 (0.06 MB
DOC)
Figure S4 Distributions of observed and expected inter-CNV
region distances. A: Histograms of the two distributions, with
observed values in blue and expected in red. B: QQ-plot of the
distributions.
Found at: doi:10.1371/journal.pone.0012839.s004 (0.30 MB
DOC)
Figure S5 Schematic diagram of rotational permutation. 1: Start
with CNV regions on a genome. The start and end of the genome
are delimited by vertical green lines, the chromosomes by blue
lines, and the CNV regions by red rectangles. 2: Wrap the genome
into a circle. 3: Rotate the CNV regions by a random number of
bases. 4: Unwrap the genome so that it is possible to measure the
overlap with the biological attribute of interest.
Found at: doi:10.1371/journal.pone.0012839.s005 (0.15 MB
DOC)
Table S1 Perlegen SNPs. Number of autosomal SNPs identified
by Frazer, et al. in the seven test strains, when compared to
C57BL/6J.
Found at: doi:10.1371/journal.pone.0012839.s006 (0.02 MB
XLS)
Table S2 2.1M array probes with SNP content. For each strain,
the total number of probes which contain SNPs is listed. Subtotals
are given for probes with one, two, three or four annotated SNPs.
Results are shown as a percentage of the total number of 2.1M
probes considered in this analysis.
Found at: doi:10.1371/journal.pone.0012839.s007 (0.03 MB
XLS)
Table S3 SNP effect depends on position within probe. Log2
ratios of probes containing one SNP were classified by the position of
the SNP within the probe. The log2 ratios from probes with central
SNPs were compared to the log2 ratios from probes with edge SNPs
using a Mann-Whitney U test. P-values from these comparisons are
shown for each strain and experiment (d.s. = dye swap).
Found at: doi:10.1371/journal.pone.0012839.s008 (0.02 MB
XLS)
Table S4 CNV coordinates. Genomic coordinates are given for
the putative CNVs detected in each strain. Median P-values from
the SW-ARRAY analysis of the normal dye and dye swap
experiments are given. Also shown are the mean and median
standardized log2 ratios for each CNV, in both the normal dye and
dye swap experiments.
Found at: doi:10.1371/journal.pone.0012839.s009 (0.41 MB
XLS)
Table S5 CNV region coordinates. CNV region coordinates
and strain distribution patterns. Strains that harbour a CNV in a
CNV region are denoted with a ‘1’.
Found at: doi:10.1371/journal.pone.0012839.s010 (0.10 MB
XLS)
Table S6 Enrichment and depletion of recombination substrates in
CNV regions. Recombination substrates were downloaded from the
University of Santa Cruz Genome Browser (http://genome.ucsc.edu)
and re-mapped to Build 37 of the mouse genome, where necessary,
using LiftOver (http://hgdownload.cse.ucsc.edu/downloads.html).
(SD = segmental duplication, LINE = long interspersed repetitive
element, SINE = short interspersed repetitive element and LTR =
long tandem repeat.) CNV regions were categorized as short
(,10Kb), medium (10 - 100 Kb), and long (.100 Kb), and were
analyzed separately. CNV regions were permuted as described in the
main text and Materials S1. Fold change was calculated as the
percentage of CNV region basepairs overlapping the recombination
substrate, divided by the expected percentage overlap (for each set of
permuted CNV regions the percentage of CNV region bases in the
substrate were recorded, and the expected percentage overlap was
estimated as the median percentage over 1000 permutations.) P-
values were calculated as described in the main text. Values shown in
black text are for within and around the CNV region (up to 10 Kb
away from the breakpoint), values in green refer only to enrichment
(depletion) within regions, and values in red refer only in the
neighboring segments. A ‘-’ indicates that no significant enrichment
or depletion was detected.
Found at: doi:10.1371/journal.pone.0012839.s011 (0.02 MB
XLS)
Table S7 Statistically significant over- or under- representation
of Gene Ontology terms in mouse-CNV regions. FDR is 5%. Note
that any gene which is at least partially overlapped by a CNV
region was included in this analysis.
Found at: doi:10.1371/journal.pone.0012839.s012 (0.02 MB
XLS)
Table S8 Expression variance of transcripts in CNV regions, in
genomic segments near to CNV regions, and further away from
CNV regions. We analysed the effect of CNV on gene epxression.
We used genome-wide expression data in three tissues (brain
(hippocampus), liver and lung), from 42 animals (five individuals
from A/J, AKR/J, BALB/cJ, C3H/HeJ, DBA/2J and C57BL/6J,
and four from AKR/J, CBA/J and LP/J), measured on Illumina
expression arrays (Huang, et al. 2009). For each tissue we had a set
of measured transcripts, and for each transcript the data consisted
of its average expression level in each strain, and an ANOVA logP
(that is, the negative, log10, P-value) measuring its differential
expression across the eight strains. Median logPs are given for
transcripts within CNV regions, within 250 to 450 Kb of CNV
regions, 450 to 650 Kb away, and more than 650 Kb from the
nearest CNV region breakpoint. P-values fron Mann-Whitney U
tests that compare the logP values from one set of transcripts to
those from all transcripts that are further away are also given.
Found at: doi:10.1371/journal.pone.0012839.s013 (0.02 MB
XLS)
Table S9 Comparing expression levels of transcripts in deletions,
non-CNV regions, and gains. P-values from Mann-Whitney U
tests, when expression levels of deletion transcripts are compared
to those from non-CNV transcripts (P-value1), and when non-
CNV transcripts are compared to gain transcripts (P-value2).
Results are shown for each strain/tissue pair.
Found at: doi:10.1371/journal.pone.0012839.s014 (0.02 MB
XLS)
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Table S10 Collated mouse CNVs from published aCGH
studies. Genomic coordinates are given for the CNVs published
in four aCGH based studies, as well as those published here.
Where necessary, coordinates have been re-mapped to Build 37
using liftOver (http://genome.ucsc.edu/cgi-bin/hgLiftOver). De-
letions, gains and complex CNVs (‘complex’ is defined in Cahan,
et al. 2009) are given in three separate groups. Within each group
CNVs are listed in alphabetical strain order, and within each
strain they are listed in genomic order. For each CNV we show the
originating study in which it was located, at the exact coordinates
listed, and in the last six columns of the table we indicate which of
the remaining studies detected any overlapping CNV, with
matching directionality (gain or deletion), on that strain (minimum
overlap = 1 bp): ‘-1’ indicates that a strain was not included in a
study; ‘0’ indicates no overlapping CNV; and ‘1’ indicates overlap.
Note that because the type of complex CNVs (i.e., whether
deletion or gain) detected in the Cahan, et al. 2009 study were not
published, it was not possible to determine whether the overlap
with these CNVs was also matched for direction. Therefore we
annotate complex CNVs with the label ‘Cahan.complex’ in the
‘Originating Study’ column, and such CNVs are listed in the
deletion and gain groups dependent on the types of CNVs which
overlap them (so they will appear in both lists if they overlap
deletions and gains in other studies). In addition there are two
columns for the Cahan study: ‘Cahan’ and ‘Cahan.complex’; this
is to distinguish overlap of a given CNV by a complex CNV
(where matching direction could not be established) from overlap
by a Cahan deletion or gain (where matched directionality to the
CNV in question could be determined). Finally, the group of
complex CNVs listed in the last part of the table are those which
do not overlap with a CNV from any other study.
Found at: doi:10.1371/journal.pone.0012839.s015 (1.53 MB
XLS)
Table S11 Summary of CNVs found using the 385K array.
Numbers and total sizes of and fraction of the genome covered by
putative deletions and gains detected in each strain using the 385K
array.
Found at: doi:10.1371/journal.pone.0012839.s016 (0.02 MB
XLS)
Table S12 Classification of CNV regions as simple/complex/
false positive, primer details and PCR results. Column 1 gives the
chromosome. Column 2 and 3 are the start and stop coordinates
respectively, mapped onto Mouse Build37. Column 4 is the type of
CNV region, either deletion or gain. Column 5 is the predicted
SDP (C57BL/6J is always 0). Column 6 is the detection array
(2.1M stands for the NimbleGen 2.1 million probe array, 385K for
the NimbleGen 385,000 probe array). 2.1Ms refers to manual calls
detected using NimleGen detection software SignalMap. Columns
7, 8, 9, 10 and 11 give numbers of PCR primers, real-time
primers, sequenced fragments, MLPA primers and BACs used for
FISH, respectively. Column 12 is the classification as simple,
complex or false positive (as defined in the main text). NA is used
when PCR data is not sufficient to classify the CNV region.
Column 13 gives the primer name. A letter code is added at the
end of the primer name: ‘‘rt’’ for real-time primers, ‘‘s’’ for
fragments PCR’ed then sequenced and ‘‘mlpa’’ for MLPA
primers. Column 14 is the primer sequence. Column 15 is the
expected length of the amplicon (in bp). Column 16 gives the start
coordinate of the primer in bp (Mouse Build37). Seven primers
lying in a gain region on chromosome 8 (from 19,675,977bp to
20,032,624bp) failed to map onto mouse Build37 (the initial
primer design was in Build36). And Column 17 (final column) is
the average PCR result of the three independent reactions. 0 refers
to no amplification in case of qualitative PCR and MLPA; and to
an increase of copy number in case of quantitative PCR. The
reference strain is always 1, referring to amplification and normal
copy. For qualitative PCR, 2 is used to indicate amplification but
with a different size amplicon than expected (for example when
there is a short indel in the fragment). For quantitative PCR, 2
indicates a decrease in copy number. 13 primer pairs (out of 429)
failed to amplify in three independent attempts.
Found at: doi:10.1371/journal.pone.0012839.s017 (0.17 MB
XLS)
Table S13 Experimental validation carried out by previous
mouse CNV studies. Column 1 gives the reference of the mouse
CNV study, column 2 is the array type used for the detection of
the CNVs, column 3 gives the number of assessed CNV regions
and column 4 gives the total number of primers used for
independent validation.
Found at: doi:10.1371/journal.pone.0012839.s018 (0.02 MB
XLS)
Materials S1
Found at: doi:10.1371/journal.pone.0012839.s019 (0.06 MB
DOC)
Methods S1
Found at: doi:10.1371/journal.pone.0012839.s020 (0.03 MB
DOC)
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